Cargando…
Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells
Less is known about the roles of eukaryotic initiation factor alpha (eIF2α) in cholangiocarcinoma (CCA). Here, we report that eIF2α inhibitor salubrinal inhibits the proliferation of human CCA cells. Clinical application of mammalian target of rapamycin (mTOR) inhibitors only has moderate antitumor...
Autores principales: | Zhao, Xiaofang, Zhang, Chunyan, Zhou, Hong, Xiao, Bin, Cheng, Ying, Wang, Jinju, Yao, Fuli, Duan, Chunyan, Chen, Run, Liu, Youping, Feng, Chunhong, Li, Hong, Li, Jing, Dai, Rongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356752/ https://www.ncbi.nlm.nih.gov/pubmed/27863431 http://dx.doi.org/10.18632/oncotarget.13408 |
Ejemplares similares
-
JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction
por: Feng, Chunhong, et al.
Publicado: (2014) -
Synergistic Apoptosis Induction in Leukemic Cells by the Phosphatase Inhibitor Salubrinal and Proteasome Inhibitors
por: Drexler, Hannes C. A.
Publicado: (2009) -
Protective Effects of Salubrinal on Liver Injury in Rat Models of Brain Death
por: Wang, Tao, et al.
Publicado: (2015) -
Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
por: Wang, Cun, et al.
Publicado: (2012) -
Neuroprotection by salubrinal treatment in global cerebral ischemia
por: Anuncibay-Soto, Berta, et al.
Publicado: (2016)